BPBT
VRTX icon

Boston Private Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Boston Private Bank & Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$3.02M Buy
25,564
+570
+2% +$68.3K 0.14% 153
2014
Q4 		$2.97M Sell
24,994
-839
-3% -$94.5K 0.14% 155
2014
Q3 		$2.9M Sell
25,833
-195
-0.7% -$18.6K 0.14% 151
2014
Q2 		$2.46M Buy
26,028
+2,365
+10% +$166K 0.12% 166
2014
Q1 		$1.67M Buy
23,663
+185
+0.8% +$14.7K 0.08% 188
2013
Q4 		$1.74M Buy
23,478
+6,134
+35% +$427K 0.09% 186
2013
Q3 		$1.31M Sell
17,344
-70
-0.4% -$5.57K 0.07% 210
2013
Q2 		$1.39M Buy
+17,414
New +$1.28M 0.08% 200

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Boston Private Bank & Trust's VRTX Position: Q1 2015 in Review

Boston Private Bank & Trust increased its Vertex Pharmaceuticals (VRTX) stake by 2.3% in Q1 2015, buying an estimated $68.3K and bringing the position to 25,564 shares worth $3.02M. The position accounts for 0.14% of the portfolio, ranked #153.

Boston Private Bank & Trust first reported a position in VRTX in Q2 2013 and has held it in 8 quarters since. 480 funds tracked by Wall St. Rank hold VRTX as of Q1 2015.

  • Boston Private Bank & Trust held 25,564 shares of Vertex Pharmaceuticals worth $3.02M as of Q1 2015.
  • Boston Private Bank & Trust bought 570 Vertex Pharmaceuticals shares in Q1 2015, an estimated $68.3K.
  • Vertex Pharmaceuticals made up 0.14% of Boston Private Bank & Trust's portfolio in Q1 2015, its #153 holding.
  • Boston Private Bank & Trust first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 8 quarters since.
  • 480 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.